I don't want the Committee to devolve into a CEO whack a mole, ends up with no serious legislation as a result.

If we could do that and we could reduce the significant amount that we are paying in rebates to intermediaries who are not passing those rebates on to lower out-of-pocket costs, speaking on behalf of Bristol-Myers Squibb, we could work…

Each of us who voted for it, we were the deciding vote. And I know not everybody likes that, but it is working.

I think we got some good bipartisan legislation.

I understand there is no one more eloquent than Chair Sanders on Medicare for all.

The goal was to haul you guys in, decry capitalism, and blame these corporations for the high cost of drug prices.

I think we got some good bipartisan legislation.

I think we need them. There are a lot of what we have all been focusing on in our testimony and in the question and answers, and I do think it will--it can benefit patients if we move in that direction, so I am very supportive of what you…

Folks want real answers. They want relief from high prices.

I understand there is no one more eloquent than Chair Sanders on Medicare for all.

If we were able to pass meaningful reform, meaning a reform that would delink the revenues of the PBMs and insurance companies from the list price, and that would pass rebates and discounts to the patients, I would anticipate two things.

Canada is struggling with specialty care.

If we were able to pass a meaningful PBM reform bill, what would that do to the cost that American patients are paying out of pocket for pharmaceuticals?

Together with my colleagues here who voted for the Inflation Reduction Act, we said for a long time that we ought to be negotiating on prescription drug prices and we did it.

I think we need them. There are a lot of what we have all been focusing on in our testimony and in the question and answers, and I do think it will--it can benefit patients if we move in that direction, so I am very supportive of what you…

If we could do that and we could reduce the significant amount that we are paying in rebates to intermediaries who are not passing those rebates on to lower out-of-pocket costs, we could work almost immediately to begin to bring down list…

This administration has held fast the position that national security concerns remain sacrosanct and out of bounds for multilateral body to consider.

When you make a charge that a group of colleagues do not care about atrocities against Christians, I think you should take great care. And I consider that a smear.